Assessment of the efficacy of Cytoflavin in the acute phase of ischemic stroke: a systematic review and meta-analysis
- 7 August 2026
- journal article
- review article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7)
Abstract
Objective. To evaluate the effectiveness of Cytoflavin in conjunction with standard therapy compared to standard therapy alone in patients presenting during the acute phase of ischemic stroke (IS). Material and methods. A systematic literature review and meta-analysis were conducted to assess the efficacy of Cytoflavin (containing inosine, nicotinamide, riboflavin, and succinic acid; STPF POLYSAN, Ltd., Russia) in adult patients diagnosed with IS. The analysis encompassed both randomized and non-randomized controlled trials, assessing outcomes such as hospital mortality, neurological deficit (measured using the National Institutes of Health Stroke Scale, NIHSS), and functional outcomes (assessed using the modified Rankin Scale and Barthel Index). Results. The incorporation of Cytoflavin into standard treatment protocols was associated with a statistically significant reduction in mortality rates when compared to standard therapy alone (hazard ratio [HR]=0.53; 95% confidence interval [CI] 0.37; 0.76, p<0.001). Furthermore, there was a notable improvement in the regression of neurological deficits during the acute phase of IS, as evidenced by higher NIHSS scores and better functional outcomes (Barthel Index) in patients receiving Cytoflavin. Conclusion. The findings from this systematic review and meta-analysis indicate that the addition of Cytoflavin to standard therapy for ischemic stroke is associated with more favorable clinical outcomes, including decreased mortality, diminished neurological impairment, and improved functional outcomes at the end of the IS acute phase. It is imperative to consider the high heterogeneity in the functional scales data across studies when interpreting these effects.Keywords
This publication has 15 references indexed in Scilit:
- Social and economic burden of stroke in Russian FederationS.S. Korsakov Journal of Neurology and Psychiatry, 2023
- Results of a clinical and experimental study of the safety and efficacy of Cytoflavin in combination with reperfusion therapy for ischemic strokeS.S. Korsakov Journal of Neurology and Psychiatry, 2023
- Long-term survival of patients with various types of cerebrovascular accident: data from the outpatient part of the REGION-M registryCardiovascular Therapy and Prevention, 2023
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Neurology, 2021
- Meta-analytic assessment of parenteral cytoflavin effectiveness in different neurologic disordersS.S. Korsakov Journal of Neurology and Psychiatry, 2017
- Study cytoflavin dose-dependent effect in the treatment of acute ischemic strokeS.S. Korsakov Journal of Neurology and Psychiatry, 2017
- Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndromeS.S. Korsakov Journal of Neurology and Psychiatry, 2016
- The use of cytoflavin in reperfusion in ischemic strokeS.S. Korsakov Journal of Neurology and Psychiatry, 2016
- Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trialS.S. Korsakov Journal of Neurology and Psychiatry, 2015
- Effects of Early Correction of Energy and Free Radical Homeostasis on the Clinical and Morphological Picture of Cerebral InfarctionNeuroscience and Behavioral Physiology, 2011